Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

70.15

+0.88 (1.27%)

At close: Jun 12, 2026, 4:00 PM EDT

70.14

-0.01 (-0.01%)

After-hours: Jun 12, 2026, 5:16 PM EDT

Cytokinetics Revenue by Segment

Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
License	76.28M	64.35M	64.35M	64.35M	-	-	-	-
Milestone	15.00M	15.00M	15.00M	15.00M	15.00M	15.00M	1.00M	1.00M
Milestone Growth	-	-	1,400.00%	1,400.00%	1,400.00%	328.57%	-60.00%	-60.00%
Research and Development	9.74M	8.69M	7.86M	6.39M	4.22M	3.47M	2.22M	2.13M
Research and Development Growth	131.01%	150.03%	254.12%	199.20%	53.27%	-13.80%	-58.25%	-71.36%
Net Product	4.79M	-	-	-	-	-	-	-